Other Species / Isoforms
  FBX5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
P13
CSCALRPPRCSCSAS
0 1
FBX5 (human) CSCALRPPRCSCSAS P13
FBX5 (mouse) CSDLRRPsSCPCRLG S13-p
K64-ub
HSGLKLVkPDDIGRL
0 2
FBX5 (human) HSGLKLVkPDDIGRL K64-ub
FBX5 (mouse) LSELEVVKPEDSGIE K55
K84-ub
AYLEGSCkDCIKDyE
0 1
FBX5 (human) AYLEGSCkDCIKDyE K84-ub
FBX5 (mouse) under review -
Y90-p
CkDCIKDyERLSCIG
Upstream
0 30
Treatment
  • ephrin_B1
FBX5 (human) CkDCIKDyERLSCIG Y90-p
FBX5 (mouse) CNDCVRNHERLsFID H81
S94
IKDyERLSCIGsPIV
0 1
FBX5 (human) IKDyERLSCIGsPIV S94
FBX5 (mouse) VRNHERLsFIDsPIV S85-p
S98-p
ERLSCIGsPIVsPRI
Upstream
0 8
Treatment
  • AZD1152
  • ZM447439
FBX5 (human) ERLSCIGsPIVsPRI S98-p
FBX5 (mouse) ERLsFIDsPIVGHDN S89-p
S102-p
CIGsPIVsPRIVQLE
Upstream
0 9
Treatment
  • AZD1152
  • ZM447439
FBX5 (human) CIGsPIVsPRIVQLE S102-p
FBX5 (mouse) FIDsPIVGHDNKENQ G93
Y142-p
ALETSRLyEDsGYSs
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein stabilization
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • BCR-ABL1 (human)
Treatment
  • SU6656
FBX5 (human) ALETSRLyEDsGYSs Y142-p
FBX5 (mouse) ELEASRLYEDsGYSs Y121
S145-p
TSRLyEDsGYSsFSL
Upstream
2 0
Kinase, in vitro:
  • PLK1 (human)
FBX5 (human) TSRLyEDsGYSsFSL S145-p
FBX5 (mouse) ASRLYEDsGYSsFTQ S124-p
S149-p
yEDsGYSsFSLQSGL
Upstream
2 0
Kinase, in vitro:
  • PLK1 (human)
FBX5 (human) yEDsGYSsFSLQSGL S149-p
FBX5 (mouse) YEDsGYSsFTQSDRD S128-p
S182
SCLLQIQSPDQYPNK
0 3
FBX5 (human) SCLLQIQSPDQYPNK S182
FBX5 (mouse) ARLLPSQsPDQHPNK S157-p
K238-ub
LQNIIGRkMGLECVD
0 1
FBX5 (human) LQNIIGRkMGLECVD K238-ub
FBX5 (mouse) LQNIIGKKMGLEHLD K213
K289-ub
KKILEDDkGAFQLYS
0 1
FBX5 (human) KKILEDDkGAFQLYS K289-ub
FBX5 (mouse) KKILENNKGAFQLYS K264
K297-ub
GAFQLYSkAIQRVTE
0 1
FBX5 (human) GAFQLYSkAIQRVTE K297-ub
FBX5 (mouse) GAFQLYSKTMQRVIE K272
K308-ub
RVTENNNkFSPHAST
0 2
FBX5 (human) RVTENNNkFSPHAST K308-ub
FBX5 (mouse) QRVIESSKLSLHATT K282
Y318-p
PHASTREyVMFRtPL
0 2
FBX5 (human) PHASTREyVMFRtPL Y318-p
FBX5 (mouse) LHATTRGYVVGRAAL Y292
T323-p
REyVMFRtPLASVQK
0 1
FBX5 (human) REyVMFRtPLASVQK T323-p
FBX5 (mouse) RGYVVGRAALTCVQK A297
S331-p
PLASVQKsAAQtsLK
0 1
FBX5 (human) PLASVQKsAAQtsLK S331-p
FBX5 (mouse) ALTCVQKSSTWAPPK S305
T335-p
VQKsAAQtsLKKDAQ
0 1
FBX5 (human) VQKsAAQtsLKKDAQ T335-p
FBX5 (mouse) VQKSSTWAPPKKDVQ A309
S336-p
QKsAAQtsLKKDAQT
0 1
FBX5 (human) QKsAAQtsLKKDAQT S336-p
FBX5 (mouse) QKSSTWAPPKKDVQI P310
K344-ub
LKKDAQTkLsNQGDQ
0 1
FBX5 (human) LKKDAQTkLsNQGDQ K344-ub
FBX5 (mouse) PKKDVQIKSSSQRGQ K318
S346-p
KDAQTkLsNQGDQkG
0 1
FBX5 (human) KDAQTkLsNQGDQkG S346-p
FBX5 (mouse) KDVQIKSSSQRGQRV S320
K352-ub
LsNQGDQkGSTySRH
0 4
FBX5 (human) LsNQGDQkGSTySRH K352-ub
FBX5 (mouse) SSSQRGQRVSTYSRH R326
K352-sm
LsNQGDQkGSTySRH
0 1
FBX5 (human) LsNQGDQkGSTySRH K352-sm
FBX5 (mouse) SSSQRGQRVSTYSRH R326
Y356-p
GDQkGSTySRHNEFS
0 1
FBX5 (human) GDQkGSTySRHNEFS Y356-p
FBX5 (mouse) RGQRVSTYSRHNEFV Y330
K367-ub
NEFSEVAkTLKKNES
0 1
FBX5 (human) NEFSEVAkTLKKNES K367-ub
FBX5 (mouse) NEFVEVAKTLKNNES K341
S383-p
KACIRCNsPAKyDCY
0 1
FBX5 (human) KACIRCNsPAKyDCY S383-p
FBX5 (mouse) KACVRCNFPAKYDHY F357
Y387-p
RCNsPAKyDCYLQRA
0 1
FBX5 (human) RCNsPAKyDCYLQRA Y387-p
FBX5 (mouse) RCNFPAKYDHYLERA Y361
T437-p
KIGPLPGtKKSKKNL
0 1
FBX5 (human) KIGPLPGtKKSKKNL T437-p
FBX5 (mouse) KVGPLPGTKKSkKNL T411
K441
LPGtKKSKKNLRRL_
0 1
FBX5 (human) LPGtKKSKKNLRRL_ K441
FBX5 (mouse) LPGTKKSkKNLQRL_ K415-ub